ow dose versus standard dose oxytocin in pregnant women undergoing elective caesarean delivery

Phase 4

Completed

• Conditions: Obstetric anaesthesia for elective caesarean section; Anaesthesiology - Anaesthetics; Reproductive Health and Childbirth - Other reproductive health and childbirth disorders

• Registration Number: ACTRN12616000398404
• Lead Sponsor: Royal Hobart Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-03-29
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 66

Inclusion Criteria

ASA I –II, term pregnancy (>38 weeks), aged 18 to 40 years and scheduled for elective caesarean delivery.

Exclusion Criteria

Clinical history of hypertensive disorders (pre eclampsia; chronic hypertension), haemodynamic instability (systolic blood pressure < 100 mmHg), bleeding diastasis (thrombocytopenia, coagulopathies) and history of uterine atony causing post-partum haemorrhage.

Study & Design

• Study Type: Interventional
• Study Design: Not specified